Canada Suspends AstraZeneca Vaccine Over Safety Concerns for Patients Under 55
Canada’s National Advisory Committee on Immunization suspended the Oxford-AstraZeneca coronavirus vaccine for people under the age of 55 on Monday after reports of potential blood clots in users.